Clinical Trial Update: A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating HB2198 in adults with systemic lupus erythematosus, including lupus nephritis, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• HB2198

Snippet

Sponsor: Hinge Bio | Conditions: Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN) | Phase 1 | Status: RECRUITING